Re: Boyer et al.: Outcomes with as-needed ranibizumab after initial monthly therapy: long-term outcomes of the phase III RIDE and RISE trials (Ophthalmology 2015;122:2504-13)
- PMID: 27210607
- DOI: 10.1016/j.ophtha.2015.11.033
Re: Boyer et al.: Outcomes with as-needed ranibizumab after initial monthly therapy: long-term outcomes of the phase III RIDE and RISE trials (Ophthalmology 2015;122:2504-13)
Comment on
-
Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy: Long-Term Outcomes of the Phase III RIDE and RISE Trials.Ophthalmology. 2015 Dec;122(12):2504-13.e1. doi: 10.1016/j.ophtha.2015.08.006. Epub 2015 Oct 9. Ophthalmology. 2015. PMID: 26452713 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources